Jeon, D., Moseman, J.E., Hill, E., and McNeel, D.G. Toll like receptor agonist effects on human CD8+ T cell activation and expression of T cell checkpoint receptors. Human Vaccine Immunother., 21(1): 2598694, 2025.
Moseman, J.E., Brinkman, H.M., Choe, J.A., Shim, D., Burger, J.C., Ferraresso, F., Rastogi, I., Kastrup, C.J., Murphy, W.L., and McNeel, D.G. Plasmid DNA Vaccines Encapsulated in Lipid Nanoparticles Elicit STING-dependent Type 1 Interferon Release. Mol. Ther. Adv., 34(1): 201698, 2026.
Gao, A., Khatri, P.H., Ma, G., Liu, P. Fernandez-Martinez, A., Donahue, K., Wang, Y., Kim. E.-J., Hu, M., Liu, F. Zhou, J., Chan, N.T., Yang, X., Schwartz, R.W., Ong, I.M., Burkard, M.E., Wisinski, K.B., Perou, C.M., Dinh, H.Q., and Xu, W. Integrated multi-omic profiling identified BRD8/EP400 as a pivotal chromatin module mediating anti-HER2 response in HR+/HER2+ breast cancer. Cancer Res., epub ahead of print, March 26, 2026.
Cosper, P.F., Paracha, M., Jones, K.M., Hrycyniak (Funk), L., Henderson, L., Bryan, A., Eyzaguirre, D., McCunn, E., Boulanger, E., Wan, J., Nickel, K.P., Horner, V., Hu, R., Harari, P.M., Kimple, R.J., and Weaver, B.A. Pretreatment chromosomal Instability correlates with radiation sensitivity in squamous cell cancers. Int. J. Radiat. Oncol. Biol. Phys., S0360-3016(25)06591-5, 2026.
Hoi, X.P., Stangis, M.M., Glass, S.E., Kim, J.H., Kang, S.W., Brennen, W.N., Li, Z., Grady, W.M., Yegnasubramanian, S., Kuhn, P., Lyssiotis, C.A., Sagara, A., Shrubsole, M.J., Kadara, H., Yuan, Y., Coffey, R.J., Lau, K.S., De Marzo, A.M., Maitra, A., Min, J.; TBEL Consortium. Cellular senescence in precancer lesions and early-stage cancers. Cancer Cell, S1535-6108(25)00447-7, 2025. 44(1): 6-11, 2026.